Clinical Trial Information A Randomized Phase 3 Trial of Continuous vs. Intermittent Maintenance Therapy with Zanubrutinib as Upfront Treatment in Older Patients with Mantle Cell Lymphoma Protocol Number: A052101 Status: Open Age Group: Adult Treatment Type: Treatment Secondary Protocol No.: A052101 Phase: III NCT ID: NCT05976763 Scope Information Scope: National Disease Site(s): Non-Hodgkin Lymphoma
